当前位置: X-MOL 学术Neuropsychol. Rehabilit. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
What is known about the cost-effectiveness of neuropsychological interventions for individuals with acquired brain injury? A scoping review
Neuropsychological Rehabilitation ( IF 2.7 ) Pub Date : 2019-11-26 , DOI: 10.1080/09602011.2019.1692672
Renerus J. Stolwyk 1, 2 , James R. Gooden 1, 2 , Joosup Kim 3, 4 , Dominique A. Cadilhac 3, 4
Affiliation  

The aim of this scoping review was to examine the literature related to economic evaluations of neuropsychological rehabilitation in individuals with acquired brain injury (ABI). PsychINFO, Medline, EMBASE, Cochrane and CINHAL databases were searched in accordance with formal scoping review methodology. Studies were included if published between 1995 and 2019 with a study population of adults aged 18 years or more with any ABI aetiology and there was reported data on resource use, costs or comparative economic analyses as part of an outcome study for rehabilitation interventions. Case studies and trial protocols were excluded. Of 3575 records screened, 30 articles were identified as meeting the inclusion criteria. The majority of studies documented cost savings from provision of various models of multidisciplinary inpatient or outpatient rehabilitation. However, these benefits were estimated without a control group. Eight studies included a cost-effectiveness analysis, and in three, the intervention was reported to be cost-effective compared to the control, one of which saved $9,654 per treated patient. Overall, few eligible studies were identified. Those that included a cost-effectiveness analysis yielded mixed evidence for interventions to be considered cost-effective for ABI. Recommendations for how to incorporate cost-effectiveness analyses into intervention studies are discussed.

中文翻译:

对获得性脑损伤患者进行神经心理学干预的成本效益如何?范围审查

本范围审查的目的是检查与获得性脑损伤 (ABI) 个体神经心理康复经济评估相关的文献。根据正式的范围审查方法检索 PsychINFO、Medline、EMBASE、Cochrane 和 CINHAL 数据库。如果在 1995 年至 2019 年间发表的研究对象为 18 岁或以上具有任何 ABI 病因的成年人,并且有报告的资源使用、成本或比较经济分析数据作为康复干预结果研究的一部分,则纳入研究。案例研究和试验方案被排除在外。在筛选的 3575 条记录中,30 篇文章被确定为符合纳入标准。大多数研究记录了提供各种多学科住院或门诊康复模式的成本节约。然而,这些益处是在没有对照组的情况下估计出来的。八项研究包括成本效益分析,其中三项研究报告称,与对照相比,干预具有成本效益,其中一项为每位接受治疗的患者节省了 9,654 美元。总体而言,很少有符合条件的研究被确定。那些包括成本效益分析的干预措施被认为对 ABI 具有成本效益,产生了混合证据。讨论了如何将成本效益分析纳入干预研究的建议。据报道,与对照组相比,干预措施具有成本效益,其中一种干预为每位接受治疗的患者节省了 9,654 美元。总体而言,很少有符合条件的研究被确定。那些包括成本效益分析的干预措施被认为对 ABI 具有成本效益,产生了混合证据。讨论了如何将成本效益分析纳入干预研究的建议。据报道,与对照组相比,干预措施具有成本效益,其中一种干预为每位接受治疗的患者节省了 9,654 美元。总体而言,很少有符合条件的研究被确定。那些包括成本效益分析的干预措施被认为对 ABI 具有成本效益,产生了混合证据。讨论了如何将成本效益分析纳入干预研究的建议。
更新日期:2019-11-26
down
wechat
bug